JPH0378400B2 - - Google Patents

Info

Publication number
JPH0378400B2
JPH0378400B2 JP58101874A JP10187483A JPH0378400B2 JP H0378400 B2 JPH0378400 B2 JP H0378400B2 JP 58101874 A JP58101874 A JP 58101874A JP 10187483 A JP10187483 A JP 10187483A JP H0378400 B2 JPH0378400 B2 JP H0378400B2
Authority
JP
Japan
Prior art keywords
carbolactone
ene
pregn
methylene
spironolactone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58101874A
Other languages
English (en)
Japanese (ja)
Other versions
JPS595200A (ja
Inventor
Bitoraa Deiitaa
Raurento Henrii
Uiihieruto Rudorufu
Kazarusuusutentsueru Yoruge
Shiringaa Etsukeharuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS595200A publication Critical patent/JPS595200A/ja
Publication of JPH0378400B2 publication Critical patent/JPH0378400B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP58101874A 1982-06-09 1983-06-09 ６β，７β−メチレン−１７α−プレグネ−４−エン−２１，１７−カルボラクトン、その製造法及びこれを含有しアルドステロン拮抗作用を有する薬剤 Granted JPS595200A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3222265.3 1982-06-09
DE19823222265 DE3222265A1 (de) 1982-06-09 1982-06-09 6ss.7ss-methylen-17(alpha)-pregn-4-en-21.17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
JPS595200A JPS595200A (ja) 1984-01-12
JPH0378400B2 true JPH0378400B2 (en, 2012) 1991-12-13

Family

ID=6166010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58101874A Granted JPS595200A (ja) 1982-06-09 1983-06-09 ６β，７β−メチレン−１７α−プレグネ−４−エン−２１，１７−カルボラクトン、その製造法及びこれを含有しアルドステロン拮抗作用を有する薬剤

Country Status (6)

Country Link
US (1) US4464364A (en, 2012)
EP (1) EP0096358B1 (en, 2012)
JP (1) JPS595200A (en, 2012)
AT (1) ATE22298T1 (en, 2012)
DE (2) DE3222265A1 (en, 2012)
ES (1) ES8402845A1 (en, 2012)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3414508A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrfach tritiierte steroid-20.17-spirolactone und ihre verwendung als tracersubstanzen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL166267C (nl) * 1968-03-22 1981-07-15 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten, de onder toepassing daarvan verkregen gevormde voort- brengselen, alsmede werkwijze ter bereiding van 6,7-methyleen-20-spirox-4-en-3-onderivaten met aldoste- ron remmende werking.
DE2922500A1 (de) * 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta

Also Published As

Publication number Publication date
ES523126A0 (es) 1984-03-16
US4464364A (en) 1984-08-07
EP0096358B1 (en) 1986-09-17
JPS595200A (ja) 1984-01-12
ES8402845A1 (es) 1984-03-16
EP0096358A1 (en) 1983-12-21
DE3222265A1 (de) 1983-12-15
DE3366233D1 (en) 1986-10-23
ATE22298T1 (de) 1986-10-15

Similar Documents

Publication Publication Date Title
JP5626616B2 (ja) ドロスピレノンの調製方法
AU2007263944B2 (en) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same
IL184288A (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
EP0156284A2 (de) 17-Substituierte Estradiene
JP2010529153A (ja) １７β−シアノ−１９−ノル−アンドロスタ−４−エン誘導体、その使用、及び当該誘導体を含む医薬
JPH0378400B2 (en, 2012)
CA2710491C (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid .gamma.-lactone derivative, use thereof and medicinal products containing the derivative
CA2710495A1 (en) 19-nor-steroid derivatives with a 15.alpha., 16.alpha.-methylene group and a saturated 17,17-spirolactone ring, use thereof and medicinal products containing these derivatives
KR20100037596A (ko) 17β-시아노-19-안드로스트-4-엔 유도체, 그의 용도, 및 상기 유도체를 함유하는 의약
JPH0436160B2 (en, 2012)
JPS6126557B2 (en, 2012)
US8445469B2 (en) 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
DE1493114C3 (en, 2012)
DE102007063498A1 (de) 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel